RM Pharma Consulting ApS — Credit Rating and Financial Key Figures

RM Pharma Consulting ApS (CVR number: 44193000) is a company from HØRSHOLM. The company recorded a gross profit of 2169.7 kDKK in 2025. The operating profit was 152.2 kDKK, while net earnings were 114.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was 17.8 %, which can be considered excellent and Return on Equity (ROE) was 27.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 39.6 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. RM Pharma Consulting ApS's liquidity measured by quick ratio was 0.9 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.